AAAAAA
Results:
1-19
|
Results: 19
Authors:
Cartmell, J
Perry, KW
Salhoff, CR
Monn, JA
Schoepp, DD
Citation: J. Cartmell et al., Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade, NEUROPHARM, 40(7), 2001, pp. 847-855
Authors:
Cartmell, J
Monn, JA
Schoepp, DD
Citation: J. Cartmell et al., Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine, PSYCHOPHAR, 148(4), 2000, pp. 423-429
Authors:
Monn, JA
Schoepp, DD
Citation: Ja. Monn et Dd. Schoepp, Metabotropic glutamate receptor modulators: Recent advances and therapeutic potential, ANNU REP M, 35, 2000, pp. 1-10
Authors:
Cartmell, J
Monn, JA
Schoepp, DD
Citation: J. Cartmell et al., Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268, N-S ARCH PH, 361(1), 2000, pp. 39-46
Authors:
Bond, A
Jones, NM
Hicks, CA
Whiffin, GM
Ward, MA
O'Neill, MF
Kingston, AE
Monn, JA
Ornstein, PL
Schoepp, DD
Lodge, D
O'Neill, MJ
Citation: A. Bond et al., Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist:Investigations into possible mechanism of action in vivo, J PHARM EXP, 294(3), 2000, pp. 800-809
Authors:
Marek, GJ
Wright, RA
Schoepp, DD
Monn, JA
Aghajanian, GK
Citation: Gj. Marek et al., Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex, J PHARM EXP, 292(1), 2000, pp. 76-87
Authors:
Cartmell, J
Perry, KW
Salhoff, CR
Monn, JA
Schoepp, DD
Citation: J. Cartmell et al., The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat, J NEUROCHEM, 75(3), 2000, pp. 1147-1154
Authors:
Cartmell, J
Monn, JA
Schoepp, DD
Citation: J. Cartmell et al., The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing, EUR J PHARM, 400(2-3), 2000, pp. 221-224
Authors:
Cartmell, J
Salhoff, CR
Perry, KW
Monn, JA
Schoepp, DD
Citation: J. Cartmell et al., Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum, BRAIN RES, 887(2), 2000, pp. 378-384
Authors:
Moore, NA
Rees, G
Monn, JA
Citation: Na. Moore et al., Effects of the group II metabotropic glutamate receptor agonist, LY354740 on schedule-controlled behaviour in rats, BEHAV PHARM, 10(3), 1999, pp. 319-325
Authors:
Bond, A
Ragumoorthy, N
Monn, JA
Hicks, CA
Ward, MA
Lodge, D
O'Neill, MJ
Citation: A. Bond et al., LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia, NEUROSCI L, 273(3), 1999, pp. 191-194
Authors:
Benvenga, MJ
Overshiner, CD
Monn, JA
Leander, JD
Citation: Mj. Benvenga et al., Disinhibitory effects of LY354740, a new mGluR2 agonist, on behaviors suppressed by electric shock in rats and pigeons, DRUG DEV R, 47(1), 1999, pp. 37-44
Authors:
Lam, AGM
Monn, JA
Schoepp, DD
Lodge, D
McCulloch, J
Citation: Agm. Lam et al., Group II selective metabotropic glutamate receptor agonists and local cerebral glucose use in the rat, J CEREBR B, 19(10), 1999, pp. 1083-1091
Authors:
Schoepp, DD
Jane, DE
Monn, JA
Citation: Dd. Schoepp et al., Pharmacological agents acting at subtypes of metabotropic glutamate receptors, NEUROPHARM, 38(10), 1999, pp. 1431-1476
Authors:
Cartmell, J
Monn, JA
Schoepp, DD
Citation: J. Cartmell et al., The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats, J PHARM EXP, 291(1), 1999, pp. 161-170
Authors:
Monn, JA
Valli, MJ
Massey, SM
Hansen, MM
Kress, TJ
Wepsiec, JP
Harkness, AR
Grutsch, JL
Wright, RA
Johnson, BG
Andis, SL
Kingston, A
Tomlinson, R
Lewis, R
Griffey, KR
Tizzano, JP
Schoepp, DD
Citation: Ja. Monn et al., Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): Identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors, J MED CHEM, 42(6), 1999, pp. 1027-1040
Authors:
Jones, NM
Beart, PM
Monn, JA
Widdop, RE
Citation: Nm. Jones et al., Type I and II metabotropic glutamate receptors mediate depressor and bradycardic actions in the nucleus of the solitary tract of anaesthetized rats, EUR J PHARM, 380(2-3), 1999, pp. 129-135
Authors:
Kingston, AE
O'Neill, MJ
Lam, A
Bales, KR
Monn, JA
Schoepp, DD
Citation: Ae. Kingston et al., Neuroprotection by metabotropic glutamate receptor agonists: LY354740, LY379268 and LY389795, EUR J PHARM, 377(2-3), 1999, pp. 155-165
Authors:
Li, XC
Beart, PM
Monn, JA
Jones, NM
Widdop, RE
Citation: Xc. Li et al., Type I and II metabotropic glutamate receptor agonists and antagonists evoke cardiovascular effects after intrathecal administration in conscious rats, BR J PHARM, 128(3), 1999, pp. 823-829
Risultati:
1-19
|